C1512814||Image-Guided Intensity-Modulated Radiotherapy
C0153382||Oropharynx Cancer
C0160814||Late Toxic Effects
C0160814||Late toxic effects
C1522449||radiotherapy
C0436307||chemoradiotherapy
C0153382||oropharynx cancer
C0160814||late toxic effects
C3641165||narrow-margin
C1512814||image-guided intensity-modulated radiotherapy
C1512814||image-guided intensity-modulated radiotherapy
C0014507||epidemiology
C0153382||oropharynx cancer
C0160814||late toxic effects
C0087111||non-operative treatment
C0153382||oropharynx cancer
C0280313||squamous cell carcinoma of the oropharynx
C0087111||treated
C0587437||tertiary-referral academic multidisciplinary head and neck practice
C3641165||narrow-margin
C1512814||image-guided intensity-modulated radiotherapy
C0008838||cisplatin
C0160814||late toxic effects
C3888020||Common Terminology Criteria for Adverse Events
C1519275||grade 3
C1522449||radiotherapy
C0600688||Toxic effect
C0014866||esophageal stricture
C1322279||dilation
C0032290||aspiration pneumonia
C0019993||hospitalization
C0021931||feeding tube insertions
C0029461||osteoradionecrosis
C2945625||Feeding tube
C0160814||late toxic effect
C0031831||physician
C0027530||neck
C0016059||fibrosis
C0043352||xerostomia
C0035649||risks
C0011065||death
C0025663||Gray method
C4288937||HPV positive
C0008838||cisplatin
C0398395||neck dissection
C0011900||diagnosis
C1947913||locoregional
C2945625||feeding tube
C0087111||treatment
C0160814||late toxic effects
C0035649||risks
C0411582||free-flap reconstruction
C0029461||osteoradionecrosis
C0027530||neck
C0016059||fibrosis
C1560329||grade 2 xerostomia
C0160814||late toxic effects
C1512814||image-guided intensity-modulated radiotherapy
C0008838||cisplatin
C0153382||oropharynx cancer
C0160814||late toxic effect
C0008976||clinical trials